MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CLRB
  4. News
CLRB
Quote
Short
News
Articles
Message Board

Cellectar Biosciences Inc. (NASDAQ : CLRB ) News

News Releases

CLRB News Releases
CLRB : NASDAQ
GlobeNewswire
Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting
CLRB : NASDAQ
Motley Fool
Cellectar (CLRB) Q1 2026 Earnings Transcript
CLRB : NASDAQ
SeekingAlpha
Cellectar plans Phase III start in late Q4 2026 as it outlines potential WM approval in the second half of 2027
CLRB : NASDAQ
SeekingAlpha
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript
CLRB : NASDAQ
SeekingAlpha
Cellectar Biosciences Non-GAAP EPS of -$1.33
CLRB : NASDAQ
GlobeNewswire
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
CLRB : NASDAQ
SeekingAlpha
Cellectar Biosciences Q1 2026 Earnings Preview
CLRB : NASDAQ
GlobeNewswire
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
CLRB : NASDAQ
24/7 Market News
Insider Signals and Potential Moonshots that Could Reset Valuations
CLRB : NASDAQ
KlickAnalytics
CLRB Price Target Alert: $11.00. Issued by Roth Capital
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.